Published in Rambam Maimonides Med J on April 30, 2013
From big data analysis to personalized medicine for all: challenges and opportunities. BMC Med Genomics (2015) 1.04
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement (2015) 1.03
Application of metabolomics in drug resistant breast cancer research. Metabolites (2015) 0.90
Omics databases on kidney disease: where they can be found and how to benefit from them. Clin Kidney J (2016) 0.87
The new holism: P4 systems medicine and the medicalization of health and life itself. Med Health Care Philos (2016) 0.83
Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01. Pharmacogenomics J (2014) 0.80
Life course health care and preemptive approach to non-communicable diseases. Proc Jpn Acad Ser B Phys Biol Sci (2013) 0.79
Toward precision medicine and health: Opportunities and challenges in allergic diseases. J Allergy Clin Immunol (2016) 0.79
Next generation informatics for big data in precision medicine era. BioData Min (2015) 0.78
Crowdsourced direct-to-consumer genomic analysis of a family quartet. BMC Genomics (2015) 0.78
Clinical decision-making and secondary findings in systems medicine. BMC Med Ethics (2016) 0.78
Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine. Mol Cells (2013) 0.78
Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies. BMC Bioinformatics (2014) 0.77
Integrating omics technologies to study pulmonary physiology and pathology at the systems level. Cell Physiol Biochem (2014) 0.76
Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis. F1000Res (2017) 0.75
A systems approach to personalised nutrition: Report on the Keystone Symposium "Human Nutrition, Environment and Health". Appl Transl Genom (2016) 0.75
Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis. Am J Nucl Med Mol Imaging (2016) 0.75
Bridging the gap between clinicians and systems biologists: from network biology to translational biomedical research. J Transl Med (2016) 0.75
Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literature. BMJ Open (2016) 0.75
Self-tracking the microbiome: where do we go from here? Microbiome (2015) 0.75
Systems Medicine-Complexity Within, Simplicity Without. J Healthc Inform Res (2017) 0.75
Concussion As a Multi-Scale Complex System: An Interdisciplinary Synthesis of Current Knowledge. Front Neurol (2017) 0.75
Personalized medicine in rheumatology: the paradigm of serum autoantibodies. Auto Immun Highlights (2017) 0.75
Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science (2010) 18.45
Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A (2009) 6.91
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods (2012) 4.93
A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics (2011) 3.37
Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med (2011) 2.68
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat Med (2011) 2.54
A systems approach to prion disease. Mol Syst Biol (2009) 2.49
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med (2012) 2.13
A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol (2012) 2.13
Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells. Proc Natl Acad Sci U S A (2011) 1.76
Chromosomal haplotypes by genetic phasing of human families. Am J Hum Genet (2011) 1.58
Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol (2012) 1.39
Systems biology at the Institute for Systems Biology. Brief Funct Genomic Proteomic (2008) 1.30
Systems approaches to biology and disease enable translational systems medicine. Genomics Proteomics Bioinformatics (2012) 1.19
A personal journey of discovery: developing technology and changing biology. Annu Rev Anal Chem (Palo Alto Calif) (2008) 1.15
New and improved proteomics technologies for understanding complex biological systems: addressing a grand challenge in the life sciences. Proteomics (2012) 1.14
Quantitating cell-cell interaction functions with applications to glioblastoma multiforme cancer cells. Nano Lett (2012) 1.05
N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications. Mol Cell Proteomics (2013) 1.05
Principal network analysis: identification of subnetworks representing major dynamics using gene expression data. Bioinformatics (2010) 1.03
High-density, multiplexed patterning of cells at single-cell resolution for tissue engineering and other applications. Angew Chem Int Ed Engl (2011) 1.01
Microfluidics-based capture of human neutrophils for expression analysis in blood and bronchoalveolar lavage. Lab Invest (2011) 1.00
Systems biology and the discovery of diagnostic biomarkers. Dis Markers (2010) 0.95
Recent Patents and Advances in the Next-Generation Sequencing Technologies. Recent Pat Biomed Eng (2008) 0.87
Nanoparticles offer hope for TB detection. Nat Nanotechnol (2009) 0.85
Glycocapture-assisted global quantitative proteomics (gagQP) reveals multiorgan responses in serum toxicoproteome. J Proteome Res (2013) 0.85
A personal view of molecular technology and how it has changed biology. J Proteome Res (2003) 0.79
The human genome project: what impact on basic research? FASEB J (1987) 0.78